MXPA99012039A - Cosmetic composition containing a whitening agent and an exfoliant - Google Patents
Cosmetic composition containing a whitening agent and an exfoliantInfo
- Publication number
- MXPA99012039A MXPA99012039A MXPA/A/1999/012039A MX9912039A MXPA99012039A MX PA99012039 A MXPA99012039 A MX PA99012039A MX 9912039 A MX9912039 A MX 9912039A MX PA99012039 A MXPA99012039 A MX PA99012039A
- Authority
- MX
- Mexico
- Prior art keywords
- cosmetic
- acid
- skin
- derivatives
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 120
- 239000002537 cosmetic Substances 0.000 title claims abstract description 89
- 239000003795 chemical substances by application Substances 0.000 title claims description 33
- 230000002087 whitening effect Effects 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 49
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 42
- 239000002904 solvent Substances 0.000 claims description 38
- 239000003349 gelling agent Substances 0.000 claims description 24
- 239000011668 ascorbic acid Substances 0.000 claims description 23
- 235000010323 ascorbic acid Nutrition 0.000 claims description 23
- 229960005070 ascorbic acid Drugs 0.000 claims description 23
- 239000007844 bleaching agent Substances 0.000 claims description 21
- 239000004310 lactic acid Substances 0.000 claims description 21
- 235000014655 lactic acid Nutrition 0.000 claims description 21
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 20
- 230000002209 hydrophobic effect Effects 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 16
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 16
- 238000004061 bleaching Methods 0.000 claims description 16
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 15
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 15
- 229960004705 kojic acid Drugs 0.000 claims description 15
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 14
- 229920001296 polysiloxane Polymers 0.000 claims description 14
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000003463 adsorbent Substances 0.000 claims description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 10
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- 229940108325 retinyl palmitate Drugs 0.000 claims description 10
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 10
- 239000011769 retinyl palmitate Substances 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 230000003712 anti-aging effect Effects 0.000 claims description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 8
- 244000139693 Arctostaphylos uva ursi Species 0.000 claims description 7
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 claims description 7
- 229960000271 arbutin Drugs 0.000 claims description 7
- 239000000440 bentonite Substances 0.000 claims description 7
- 229910000278 bentonite Inorganic materials 0.000 claims description 7
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 7
- 229940069445 licorice extract Drugs 0.000 claims description 7
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 7
- 229960004889 salicylic acid Drugs 0.000 claims description 7
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 6
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical group CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
- 239000001630 malic acid Substances 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- 229940057400 trihydroxystearin Drugs 0.000 claims description 6
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 5
- 229920001400 block copolymer Polymers 0.000 claims description 5
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 claims description 5
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- 206010040829 Skin discolouration Diseases 0.000 claims description 4
- 229960003471 retinol Drugs 0.000 claims description 4
- 235000020944 retinol Nutrition 0.000 claims description 4
- 239000011607 retinol Substances 0.000 claims description 4
- 150000001280 alpha hydroxy acids Chemical class 0.000 abstract description 25
- 229940061720 alpha hydroxy acid Drugs 0.000 abstract description 23
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000037393 skin firmness Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 63
- 239000013543 active substance Substances 0.000 description 26
- -1 lactic acid Chemical class 0.000 description 26
- 239000002245 particle Substances 0.000 description 22
- 239000000463 material Substances 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 239000004005 microsphere Substances 0.000 description 14
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 239000001993 wax Substances 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 239000004909 Moisturizer Substances 0.000 description 11
- 230000001333 moisturizer Effects 0.000 description 11
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 10
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 229940008099 dimethicone Drugs 0.000 description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 150000007513 acids Chemical class 0.000 description 8
- 239000003974 emollient agent Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229940086555 cyclomethicone Drugs 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 206010040954 Skin wrinkling Diseases 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 208000033316 Acquired hemophilia A Diseases 0.000 description 5
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 5
- 229920000299 Nylon 12 Polymers 0.000 description 5
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 150000003408 sphingolipids Chemical class 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 150000001277 beta hydroxy acids Chemical class 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000001540 sodium lactate Substances 0.000 description 4
- 229940005581 sodium lactate Drugs 0.000 description 4
- 235000011088 sodium lactate Nutrition 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000178870 Lavandula angustifolia Species 0.000 description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 208000009621 actinic keratosis Diseases 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000012185 ceresin wax Substances 0.000 description 3
- 229940085262 cetyl dimethicone Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000001102 lavandula vera Substances 0.000 description 3
- 235000018219 lavender Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000004200 microcrystalline wax Substances 0.000 description 3
- 235000019808 microcrystalline wax Nutrition 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 229940098697 zinc laurate Drugs 0.000 description 3
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical class CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010048245 Yellow skin Diseases 0.000 description 2
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000004716 alpha keto acids Chemical class 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Chemical class CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-N cyanic acid Chemical compound OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000010954 inorganic particle Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000003605 opacifier Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001748 polybutylene Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229940057429 sorbitan isostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Chemical class 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- VHWSRELATOUTAG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-aminobenzoate Chemical compound NC1=CC=CC=C1C(=O)OCC(O)CO VHWSRELATOUTAG-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- FSSICIQKZGUEAE-UHFFFAOYSA-N 2-[benzyl(pyridin-2-yl)amino]ethyl-dimethylazanium;chloride Chemical compound Cl.C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 FSSICIQKZGUEAE-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 description 1
- FHYNZKLNCPUNEU-UHFFFAOYSA-N 4-[(3,4-dihydroxyphenyl)methyl]-3-[(4-hydroxyphenyl)methyl]oxolan-2-one Chemical compound C1=CC(O)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(O)=C1 FHYNZKLNCPUNEU-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 244000067456 Chrysanthemum coronarium Species 0.000 description 1
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000003901 Crambe Nutrition 0.000 description 1
- 241000220246 Crambe <angiosperm> Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical class CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Chemical class 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229920000535 Tan II Polymers 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HSMXEPWDIJUMSS-UHFFFAOYSA-K aluminum;tetradecanoate Chemical compound [Al+3].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O HSMXEPWDIJUMSS-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PECIYKGSSMCNHN-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=NC=N[C]21.O=C1N(C)C(=O)N(C)C2=NC=N[C]21 PECIYKGSSMCNHN-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000010480 babassu oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical compound O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000008407 cosmetic solvent Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical class CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- HJXPPCPJEYUQFQ-HNNXBMFYSA-N dodecyl (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound CCCCCCCCCCCCOC(=O)[C@@H]1CCC(=O)N1 HJXPPCPJEYUQFQ-HNNXBMFYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- QHZOMAXECYYXGP-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical class C=C.OC(=O)C=C QHZOMAXECYYXGP-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 239000012051 hydrophobic carrier Substances 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- HGPXWXLYXNVULB-UHFFFAOYSA-M lithium stearate Chemical class [Li+].CCCCCCCCCCCCCCCCCC([O-])=O HGPXWXLYXNVULB-UHFFFAOYSA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Chemical class 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 229940032044 quaternium-18 Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920005613 synthetic organic polymer Polymers 0.000 description 1
- 230000003655 tactile properties Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 229930195735 unsaturated hydrocarbon Chemical group 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
Abstract
The present invention is a stabilized cosmetic composition useful in the lightening or whitening of skin. The composition contains a stabilized active ingredient for whitening along with an alpha hydroxy acid. The present invention is also a method of improving skin tone, moisturization and skin firmness through the use of the stabilized cosmetic composition and a moisture source.
Description
COSMETIC COMPOSITION CONTAINING A BLEACHING AGENT AND AN EXFOLIANT
TECHNICAL FIELD The present invention relates to cosmetic compositions that include delivery systems that provide novel ways of delivering dermatologically active agents to cosmetically significant areas of the stratum corneum. The compositions of the invention are particularly, but not exclusively, useful as compositions for lightening the skin. The invention also includes a stabilized anhydrous delivery system for water-soluble acids. Finally, the present invention relates to a method for improving skin tone, moisturization and firmness of the skin.
BACKGROUND Many skin lightening and skin bleaching compositions have been used to reduce skin pigmentation and improve skin tone. These compositions include cushion acid and its derivatives. There are many other chemicals that have a profound physiological effect on the skin. A group of such dermatologically active compounds is that of the relatively low molecular weight alpha hydroxy carboxylic acids, for example, with 10 carbons or less. Popularly called "alpha hydroxy acids", these acids are known to have a number of useful effects on the skin. Referred to as "AHA's," alpha hydroxy acids can moisten dry skin and improve various disorders including acne, psoriasis and other skin abnormalities. The AHA's are also effective to revitalize the skin. Depending on the concentration and extent of application can cause, or stimulate, exfoliation, which is the removal of layers of keratinous or callus tissue, and stimulate the renewal of new layers of skin to provide a significant improvement in the appearance of the skin . Some AHAs that have been used to provide these benefits are the simplest alpha hydroxy acids, namely lactic acid, as well as glycolic acid, citric acid and malic acid. These acids are also known as "fruit acids" because they are found in fruits and, in the case of glycolic acid, in cane sugar. There are many other AHA's, or equivalent alpha keto acids and the like, which are known, or have been suggested for use in revitalizing the skin or otherwise providing useful dermatological skin functions. Some beta hydroxy acids, for example, salicylic acid, also have useful dermatological properties. Some such "skin acids" are described in U.S. Patent No. 5,091,171 of Yu et al, the disclosure of which is incorporated herein by reference thereto. The AHAs of interest are usually highly hydrophilic, dissolve rapidly in water and, in the case of lactic acid, become liquid at about room temperature (about 16.8 ° C). Such hydrophobicity is usually incompatible with common hydrophobic cosmetics. The anhydrous nature of such cosmetics means that small amounts of active hydrophilic agents, for example, AHA's can either lose their activity due to chemical or physical-chemical combination, or fail to be delivered to the surface of the skin in an adequately hydrophilic environment. or watery to be effective. In addition, preferred environments for such agents are significantly acidic, a condition which is difficult to provide on anhydrous, or substantially hydrobromic, treated skin surfaces. Of special importance for products that are intended for daily use is to avoid irritation. It has been found that when a bleaching agent such as kojic acid is combined with an exfoliating agent, such as an alpha hydroxy acid, more specifically lactic acid, an improved bleaching results.
BRIEF DESCRIPTION OF THE INVENTION Additional aspects of the invention will be set forth in part in the description that follows and in part will be apparent from the description, or can be learned by practicing the invention. The aspects of the invention can be realized and obtained by means of the instrumentation and combinations indicated particularly in the appended claims. According to the purpose of the invention in one of its aspects incorporated and described widely in this, is described: A topically applied cosmetic composition comprising: a) a bleaching agent selected from the group consisting of kojic acid and its derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of
Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures; b) an exfoliant selected from the group consisting of lactic acid, glycolic acid, malic acid, citric acid and salicylic acid; c) a sufficient amount of an adsorbent or carrier of particulate adsorbent to support the exfoliant; and d) a cosmetic base, the base having a sufficient amount of a film-forming agent to produce a desired cosmetic film when the cosmetic composition is applied to the skin. It is further described: A stabilized bleaching composition comprising a bleach selected from kojic acid and its derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures; and a selected gelling agent of castor oil oil derivatives, silicone polymers, silicone gums, clays, bentonite, and styrene / ethylene / propylene block copolymers. It is further described: A method for lightening the skin comprising:
Apply to the surface of the skin a source of water followed by the application to the skin of a bleaching cosmetic composition that includes: a) a bleaching agent selected from the group consisting of kojic acid and its derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures; b) an exfoliant selected from the group consisting of lactic acid, glycolic acid, malic acid, citric acid and salicylic acid; c) a sufficient amount of an adsorbent or carrier of particulate adsorbent to support the exfoliant; and d) a cosmetic base, the base having a sufficient amount of a film-forming agent to produce a desired cosmetic film when the cosmetic composition is applied to the skin. Finally, it is described: An essentially anhydrous, hydrophobic topically applied cosmetic composition comprising: a) a bleaching agent selected from the group consisting of kojic acid, ascorbic acid, and mixtures thereof; b) a lactic acid exfoliant; c) an anti-aging agent selected from Vitamin A Palmitate and retinol and its derivatives;
d) a sufficient amount of a particulate adsorbent adsorbent or carrier to support the exfoliant; and e) a cosmetic base, the base having a sufficient amount of a film forming agent to produce a desired cosmetic film when the cosmetic composition is applied to the skin. Additional aspects of the invention will be set forth in part in the description that follows, and in part will be apparent from the description, or may be learned by practicing the invention.
The purposes and aspects of the invention will be realized and obtained by means of the elements and combinations particularly pointed out in the appended claims.
DETAILED DESCRIPTION OF THE PREFERRED MODALITY Several embodiments of the invention and one or more ways of practicing the invention will now be described in more detail. Illustrative, non-limiting examples of preferred embodiments of the invention will also be described. Preferred embodiments of the invention relate to novel cosmetic compositions containing a stabilized bleaching composition, an exfoliant and an anti-aging agent to improve skin bleaching. Bleaching agents may include, but are not limited to, kojic acid and its derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures. Other bleaching agents will be apparent to the cosmetic formulator. Preferred bleaching agents for use in the present invention are kojic acid and its derivatives and ascorbic acid and its derivatives. The bleaching agent of the present invention is preferably stabilized with an anhydrous gellant. Such anhydrous gels of the present invention include, but are not limited to, castor oil derivatives, eg, trihydroxystearin; silicone polymers, silicone gums, clays, bentonite; and styrene / ethylene / propylene block copolymers. If the gellant contains metal ions, it must first be treated with an appropriate chelating agent to avoid reaction between the metal ions and the active ingredients. Suitable chelating agents are well understood by the skilled cosmetic formulation technician. The use of the gellant allows the water-soluble acids to be stabilized for inclusion in an anhydrous delivery system of the present invention. The bleaching agent of the present invention is preferably present in the cosmetic composition of the present invention in an amount of about 0.10 to about 10.0% by weight, more preferably about 0.50 to about 5.0% by weight and most preferably about 1.0. to about 3.0% by weight. The bleaching agent can be combined with the gellant before the combination with the cosmetic base or the bleaching agent and the gellant can be sequentially incorporated into the cosmetic base. An exfoliant is also used in the composition according to the present invention. The exfoliant not only improves the whitening / lightening properties of the bleaching agent but also improves the overall appearance and feel of the skin. An exfoliant may be used, such as an alpha hydroxy acid, namely lactic acid, as well as, glycolic acid, citric acid and malic acid in the cosmetic composition of the present invention. There are many other AHAs, or equivalent alpha keto acids and the like, which are known, including some beta hydroxy acids, for example salicylic acid, which may also be used in accordance with the present invention. The preferred exfoliant for use in the present invention is lactic acid. An absorbent carrier may be used in conjunction with the present invention. In accordance with the invention, a variety of materials can be used as a carrier to deliver a dermatologically active ingredient or agent, for example, an exfoliant, such as an alpha hydroxy acid to the skin in an active agent form while protecting the skin. Active ingredient of other cosmetic ingredients that can deactivate it. Suitable carrier materials include, but are not limited to, organic polymeric microspheres and inorganic particles. Some commercially available microspherical powders useful in the preparation of the cosmetic materials of this invention include organic polymeric materials, such as, polyethylene, polypropylene and copolymers thereof, polyurethane, polyesters, polyamides, polymethylmethacrylate, nylon, copolymers of ethylene acrylates and copolymers of polyvinylidene. Substantially, any non-toxic, non-irritating, cosmetically compatible organic polymeric material in an adsorptive or satisfactorily absorbent form for the purposes of this invention can be provided and that compatible with the anhydrous carrier can be used. Some examples of inorganic particles include talc, clays, modified organic clays, kaolin, mica, calcium salicylate and various carbonates of various metals, for example, calcium and magnesium. Although the carrier can function effectively in larger sizes, the carrier particles must not be very large or their presence as a component of the composition will be apparent to the user and may give a rough or sandy particulate, rather than a soft feel for the cosmetic . Thus, at least eighty percent of the particles do not exceed preferably 50 microns and more preferably do not exceed 20 microns. The particles should also not be very small, or they can be absorbed in the sebaceous follicles, which, although acceptable, is not desirable, and will provide a very small storage volume for the dermatologically active active agent. Within limits to provide a satisfactory cosmetic sensation by spraying, the carrier particles must be relatively large to be able to release the active ingredient from either the surface or through surface openings from internal volumes of the particles. Preferably, at least eighty percent of the carrier particles are in excess of 10 microns in diameter. A preferred range particularly for at least eighty percent of the particles is from 10 to 20 microns, more preferably from 10 to 15 microns. A useful average particle size is from 12 to 20 microns. Particularly preferred is a porous carrier particle wherein the liquid phase absorbed within the particle occupies, for example, 10 to 90 percent of the volume of the particle, rather than simply being retained on the surface of the particle. An absorbent matrix powder that serves as a carrier for the topical delivery of the dermatologically active agent or dermatologically active solution may comprise porous synthetic organic polymer microspheres, for example, a cosmetically acceptable polyamide such as nylon 12, in a ratio of from about 0.1 to about 40.0 percent, preferably from about 5.0 to about 20.0 percent, and "* more preferably from about 6.5 to about 10.0 percent by weight of the cosmetic composition." In addition to carrying AHA's, or other dermatologically active hydrophilic agents, the polymeric microspheres Organics impart desirable tactile properties, eg, creamy, powdery and silky qualities to consumer formulations, and increase the light dispersion qualities of the formulation.When they are discharged from AHA or other dermatologically active agents, the Organic polymeric spheres are available to absorb oils from the skin, helping to control oil penetration. Examples of dermatologically suitable active agents that can be delivered to the skin in the compositions of the invention include, but are not limited to, the following: Anesthetics, eg, benzyl alcohol, lidocaine and menthol; Astringent, for example, Virginia hamamide, benzoic acid and aluminum or aluminum / zirconium salts; Keratolytics, for example, resorcinol, salicylic acid, ascorbic acid and acetic acid; Exfoliants, for example, lactic acid, glycolic acid and other alpha or beta hydroxy acids; Vasoconstrictors, for example, phenylephrinephrine hydrochloride; external analgesics, for example, tripelenamine hydrochloride and camphor; Anti-inflammatory agents, for example, salts of glycyrrhizic acid, alpha bisabolol; Derivatives of salicylate and ibuprofen; Anti-irritants, for example, allantoin, proteins, trimethyl glycine, glycine, ascorbic acid, ferulic acid, sodium lactate; Bleaching agents, for example, ascorbyl magnesium phosphate, hydrogen peroxide, kojic acid and hydroquinone; Lipolytic agents, for example, caffeine, aminophylline, and other xanthine bases;
Pigment improvers, for example, dihydroxy acetone; sunscreens, for example, diethanolamine parametoxycinnamate, glyceryl aminobenzoate, 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid, 2-phenylbenzimidazole sulfonic acid; Moisturizers and humectants, for example, panthenol chloride, lactamiopropyl trimonium, salts of pyrrolidone carboxylic acid, and polyethylene glycol, with molecular weights from about 40 to about 10,000 daltons, propylene glycol / ethylene glycol copolymers, glycerin, polyglyceryl polymers, mono -, di-, tri- or polysaccharides or mono-, di-, tri- or reduced polysaccharides or their derivatives, propylene glycol, polypropylene glycol with molecular weights from about 100 to about 10,000 daltons, hygroscopic amino acids, peptides and polypeptides or their derivatives , glycosamin glycans, amides or esters of alpha or beta hydroxy acids, ethoxylated derivatives of glycerin, propylene glycol, butanol or pentanol, inositon and choline chloride; Nutrients, for example, vitamin C, vitamin B, folic acid, and minerals for example calcium, magnesium, iron, zinc, manganese, selenium and phosphorus. The moisturizers, when added directly to the skin lightening composition, are more preferably added in the particle carriers to avoid oxidation of the active acid bleaching agents. Equivalent to the preceding examples and other guidelines herein will suggest other dermatologically suitable active agents to be included in the compositions of the invention. Some of such agents are listed in OTC Monographs and the Physician's Desk Reference which are hereby included by reference thereto. Some of these agents, and others, are described in U.S. Patent No. 5,292,512 to Schaefer et al., The disclosure of which is also incorporated herein by reference thereto. The most preferred dermatologically active agents for use in the present invention are exfoliants, such as alpha hydroxy acids, specifically lactic acid. One or more dermatologically active agents, including an exfoliant, are present in the cosmetic composition of the present invention in a range from about 0.01 to about 20.0 weight percent of the composition may be incorporated into preferred embodts of the current composition. More preferably these agents can be added from about 0.5 to about 8.0 percent and even more preferably from about 1.0 to about 5.0 percent. Other active agents can be used in equivalent proportions depending on their activity. Although some dermatologically active agents possess properties, for example a fairly low melting point, which allows them to be absorbed or adsorbed directly to or in the carrier matrix, others are in crystalline form at room temperature, and are preferably dissolved in a solvent system hydrophilic suitable for the active agent. Preferably, also the solvent system must have little or no affinity for the anhydrous base essentially.
This is important to retain both the solvent and its active solute dermatologically in or on the carrier and to preserve the intended functionality of the dermatologically active agent. Additionally, the solvent must be suitably viscous to help further retard the migration of the active agent dermatologically from the carrier. Also, the solvent must be inert or inactive with respect to, or at least not negatively impact the functionality of the dermatologically active agent. Some classes of liquid hydrophilic solvents or dispersion phase medium which can be used alone or in combination as adjuvants to assist in loading the dermatologically active agent or agents onto or to the particular carrier include, but are not limited to, water, alcohols and ethers. A suitable class of alcohols comprises mono-, di-, tri- or polyhydroxy alcohols having the formula:
(OH) R - (CH) - (C) - (CH2) Z - R 1 I (OH) (CH)
where R = H, CH 3, or a saturated, unsaturated cyclic or branched alkyl radical containing from 1 to 20 carbons; X = 0 to 1, 000,000; Y = 0 to 100; Z = 0 to 10; and R1 = H, CH3, O-CH3, O-CH2-CH3 Suitable examples of such compounds include glycerin, propylene glycol, dipropylene glycol, propanol, isopropanol, butanol, isobutanol, pentanol, isopentanol, neopentanol, diglycerol, polyglycerol, sorbitol, polyethylene glycerol, and polyol. Suitable ethers include unsubstituted and substituted ethers, for example, UCON® fluid, Union Carbide Corp. or DOWANOL® fluids, Dow Chemical Company or CARBITOL® and CELLOSOLVE® solvents from Union Carbide. In principle, suitable viscous hydrophilic solvents or solvent mixtures can be used with the dermatologically active agent in a ratio of from about 99: 1 to about 1: 99. However, the preferred proportions are chosen to exploit the physical or physico-chemical characteristics of the solvent to deliver the active agent dermatologically in an active form in a liquid phase to be collected by the absorbent carrier particles. For this purpose, although a smaller proportion of solvent may have merit in some circumstances, higher proportions of solvent are preferred. An example of preferred proportions are from about 1: 1 to about 1: 20 parts of solvent agent, on a weight basis. While such proportions may be effective for intercellular active agents, intercellularly more potent active agents may be present, for example, hydrophilic or water soluble hormones such as corticosteroids in minor relative proportions, for example, from about 1: 99 to 1: 20. parts of solvent agents. A preferred solvent for a dermatologically active agent, for example, an alpha hydroxy acid (AHA) is glycerin. The viscosity of the solvent helps to retain the
AHA in or on the particulate carrier while the hydrophobicity allows skin moisture to draw the dissolved AHA out of the microparticle. The composition also preferably includes an anti-aging agent, such as Vitamin A palmitate or retinol derivatives, specifically, retinoic acid. The anti-aging agent improves the elasticity of the skin and minimizes the formation of fine wrinkles. The anti-aging agent is present in the cosmetic composition according to the present invention in an amount from about 0.20 to about 10.0 weight percent, more preferably about 1.0 to about 6.0 weight percent, and most preferably about 1.5 to about about 2.5 weight percent. The cosmetic base can be aqueous or anhydrous. Suitable cosmetic base materials are well understood by the skilled artisan. Although an aqueous base can be used, an anhydrous hydrophobic base is preferred. In case an aqueous base is used the expert should minimize, as much as possible, the contact between the water in the base and the active agents that can be degraded by oxidation. The essential or substantially anhydrous preferred base may provide a medium or vehicle for the dispersion of the active agent, said medium may be liquid or semi-solid, for example, a dispersant or solvent for other cosmetic ingredients that bring desired cosmetic properties to the composition . The anhydrous base can thus comprise a more or less volatile, hydrophobic, cosmetic solvent in which a gelling agent is optionally dispersed to provide a desired consistency. The cosmetic bleaching composition of the present invention is best used in conjunction with an aqueous source, most often a hydrating composition. The moisturizer is preferably applied to a surface of the skin before applying the cosmetic whitening composition. Nevertheless, this is not necessary. The whitening cosmetic composition of the present invention may contain, in addition to the active ingredients, a variety of products or processing aids. The addition of such materials is readily understood by the skilled artisan and although a variety of additives are described below, the description is not intended to be limiting. Preferably, the invention provides a film-forming agent to aid the adhesion of the particulate carrier on the skin and to help form an occlusive barrier to increase the accumulation of water at or near the surface of the skin. By film former it is meant that a continuous layer essentially of product is formed on the surface of the skin. By "occlusive" it is meant that a barrier is placed on the surface of the skin, said barrier substantially blocks or retards the loss of volatile materials from the surface of the skin and allows them to accumulate in the upper layers of the skin. For the purpose of this invention, the barrier film is preferably hydrophobic. Some kinds of suitable film forming cosmetics which can be used alone or in combination include, but are not limited to, metal soaps, waxes and film-forming emollients. Some non-limiting examples of each of these classes of film forming cosmetics will now be described. Others will be known to those skilled in the art. Metallic soaps are useful materials that function to aid in adhesion and to promote the formation of a hydrophobic film. The metal soap gelling agent or agents may be an alkaline alkanoate or aluminum alkanoate of six to twenty carbon atoms, for example, the salts of laurate, oleate, or calcium, magnesium, zinc, aluminum or lithium stearate or mixtures thereof . A cosmetic metal soap, for example zinc laurate, can be used in a proportion of from about 1.0 to about 5.0 percent, preferably about 3.0 percent by weight of the composition. Metallic soap functions as an ionic gelling agent, aids in adhesion and is added to the formation of hydrophobic film. Other useful film-forming agents are waxes. Many waxes that can function as suitable film-forming agents in the compositions of the present invention are well known in the cosmetics art. These materials are typically composed of the formula RX, in which R is a cyclic or branched chain alkyl chain, saturated or unsaturated long chain of C8 to C ?, ooo, ooo, X is -H, -OR1, or - C-OR1 1, where R1 is H, or a saturated or unsaturated cyclic or branched chain alkyl radical of
Ci, to C2; R1 1 is H or residue of a mono-, di-, tri- or polyhydroxy compound capable of forming a mono-, di-, tri- or polyester. Preferred waxes have melting points which exceed 37.8 ° C. Materials such as glyceryl wax esters, beeswax, ceresin wax, carnauba wax, candelilla wax and other pharmaceutically acceptable waxes can be used. A total wax content of from 0 to 10.0 percent is suitable for formulating cosmetics satisfactorily, according to the invention. Preferably, the total wax content does not exceed 5.0 percent and more preferably not more than 3.0 percent. Suitable waxes are, for example, glyceryl tribehenate, ceresin wax and microcrystalline wax used in proportions from about 0.00 to about 5.00 percent, preferably about 0.1 to 1.5 percent. More preferably, from about 0.25 to 0.5 percent waxes such as glyceryl tribehenate and a somewhat greater proportion of about 1 to 2 percent of a ceresin was used. The low wax content obtainable with cosmetic compositions according to the invention has the advantage of providing low drag and improved removability. The functions of the wax useful are adhesion, mpartition of a creamy touch for the product, film formation and increasing viscosity.
Other useful film-forming agents are emollients. These materials are usually liquid at temperatures between 0 ° C and 37.7 ° C. Emollients useful in the present invention include those with the following formula: CnH (2n + 2-x), where n is an integer from 6 to more than 1 million and x is 0 or an even integer no greater than n and can include branched and cyclic, saturated, unsaturated hydrocarbon chains. Examples include: mineral oil, petolato, PERMETHYL® fluids, and polybutylenes. Additional useful film-forming emollients include saturated or unsaturated, mono-, di-, tri- or poly-aminated, cyclic, alkyl esters or ethers of di, tri or polyhydroxy compounds, for example, ethylene glycol, propylene glycol, glycerin , sorbitol or polyol. Examples of such emollients include, but are not limited to, vegetable oils, for example, soybean oil, babassu oil, castor oil, cottonseed oil, Chinese bait oil, cabbage oil (crambe), knob, Danish rapeseed oil, rice bran oil, palm oil, palm kernel oil, olive oil, linseed oil, coconut oil, sunflower oil, safflower oil, peanut oil and corn oil . Preferred saturated and unsaturated vegetable oils are those having fatty acid components with 6 to 24 carbon atoms. Suitable additional emollient film-forming agents include esters of the formula: R1-C-OR2 R, - OC- (CH2) "-C-O-R2 (II II -II OOO where R, and R2 are branched or cyclic alkyl radicals , saturated, unsaturated of 2 to 24 carbon atoms and n is an integer from 2 to about 20. The novel cosmetic compositions of the invention may also contain a silicone material to provide some measure of auxiliary film-forming ability. Suitable solvents are preferably insoluble in water and include polyalkylsiloxane gums, polyarylsiloxanes, polyalkylarylsiloxanes, cyclomethicone polysiloxanes, amino functional polysiloxanes and polyethersiloxane copolymers, teachings directed to additional suitable silicone materials can be found in US Patent Nos.
4,788,006; 4,341, 799; 4, 152,416; 3,964,500; 3,208.91 1; 4,364,837 and
4,465,619, whose descriptions of all are incorporated herein by reference thereto. Another class of suitable auxiliary film-forming agents comprises substances formed by the polymerization of alkylene oxide monomers of the formula: O H (CH 2) n-C-CH 2
where n is an integer from 0 to about 3. These materials can be either a homogeneous polymer or a copolymer of two or more monomers. Examples of homogeneous polymers include polypropylene oxide and polybutylene oxide. Typically, the molecular weights of these materials are between 100 and 10,000 daltons. Additionally, these materials can be condensed with a monohydric or polyhydroxyalkyl alcohol as exemplified by the UCON® fluids of Union Carbide Corp. The film-forming agent can be used alone or in combination with other film-forming agents to achieve the desired aesthetic properties in the final preparation. A preferred range of film-forming agents is from 1 to 99%, more preferably from about 1 to 50% by weight of the composition. Suitable non-hardening film formers, for example, dimethicone, can be used in proportions from about 0.5 to about 5.0 percent, preferably about
0. 6 to 1.5 percent, and more preferably 1.0 percent. Preferred functions include film formation, skin protector or water barrier forming agent, lubricity and silky emollient. Film-improving agents, for example, mica treated with aluminum myristate, in a proportion of from about 4.0 to about 20.0 weight percent of the composition, preferably about 5.0 to 8.0 percent, and more preferably 6.5 percent may be used. Preferred film enhancer functions include adhesion to the skin, imparting a creamy and silky touch to the composition and improved hydrophobic film formation. Although strong adhesive properties can be introduced to anhydrous cosmetic compositions by incorporating waxy film-forming agents, a very high wax content causes drag and a tacky feel when applied to the cosmetic, and can result in a cosmetic that is difficult to remove. To solve this problem, the invention also provides a novel film-forming system comprising relatively high proportions of a particulate mineral gelling agent, for example, a bentonite clay based on a gelling agent, and a metal soap gelling agent. , such as, for example, zinc laurate, while only a small proportion of wax is used, if any are used. When this film system is used in cosmetic compositions containing microspheres it is possible to obtain a good anhydrous film with excellent dispersibility and without stickiness or entrainment. These desirable properties appear to result from a unique combination of the skin-adhering properties of the metallic soap with "ball-bearing" lubricity properties of the microspheres. In a practical embodiment of the invention, the loading of a carrier of an AHA, v. g., lactic acid, is achieved by dissolving the AHA in glycerin and absorbing the AHA dissolved in glycerin in porous microspheres or fine particles of polymer. This system is intended for use in a hydrophobic environment where the AHAs remain in storage within the porous microspheres. When applied to the skin, as the cosmetic is rubbed or massaged into the skin, the microspheres are swept across the surface of the skin, bringing them into contact with moisture which releases the hydrophilic system from AHA-glycerin to from the microporous polymer particles. Once discharged the hollow microspheres are now available to absorb oil, moderating oil penetration trends. The AHA is preferably charged to the carrier particles, for example, porous nylon particles in a liquid medium which must be sufficiently viscous to be maintained in the pores of the particles during formulation. The lactic acid melts at 16.8 ° C and can be absorbed into porous carrier particles, without the need for any auxiliary, at temperatures above this point of effusion, by mixing in appropriate proportions of microspheres to lactic acid, for example, about 1: 1 by weight, until the lactic acid is absorbed. Other acids, such as a mixture of fruit acids, can be similarly charged onto the carrier particles by stirring, that is, by mixing, by the use of fine powders with a particle size small enough to be contained in the pores of the carrier. The skin lightening or bleaching benefits that result from the whitening cosmetic composition may begin to be apparent only after long-term use of the cosmetic composition of the invention on a regular basis, eg daily, over a period of weeks by example, 4 or 6 weeks or more. A preferred hydrophobic vehicle for the microsphere particles loaded with active agent is a silicone gel, which is preferably formulated using a volatile silicone solvent such as a dimethicone. A preferred gelling agent is a trihydroxystearipa. A volatile solvent, for example a cyclomethicone, preferably the pentameric form, can be used as a hydrophobic carrier, for example for a cream-to-powder composition. Suitable proportions are from about 20.0 to about 70.0 weight percent of the composition. Preferably about 30 to 40 percent, and more preferably about 33.0 percent. Volatile solvents work as wetting agents although they evaporate quickly to the application. Some alternative or additional volatile silicone solvents are described hereinafter. A suitable gelling agent for a volatile solvent, for example, quaternium 18 bentonite, is present from about 1.0 to about 15.0 percent, more preferably from about 3 to 10 percent, and more preferably about 5.0 to 6.0 percent. The gelling agent physically stabilizes the composition and functions as a pigment suspension vehicle, if a pigment is present, and can also absorb oil and reduce gloss. In some formulations a humectant oil may be used.
If a wetting agent is used, for example, sorbitan isostearate, it is present in an amount of from about 1.0 to about 10.0 weight percent of the composition preferably about 3.5 to 4.5 percent, and more preferably about 4.0 percent. can be used Preferred wetting agents allow an increased capacity of solid material, and impart a hydrophobic film. In appropriate cosmetics, synthetic polymeric microspheres can be used in addition to the AHA carrier powder, for example polymethylmethacrylate, in a proportion of from 8.0 to about 20.0 weight percent of the composition, preferably about 15.0 percent and more preferably 12.0 percent. . Such additional polymeric microspheres act as touch enhancers, providing a touch of "ball bearings" in the application, and a dry, velvety feel after the application and evaporation of the solvent. Additional functions include light dispersion and imparting a powdery feel to the product. A solvent solvent of low volatility, oily, for example,
Isononyl sononanoate is useful for controlling the volatility and molecular weight of the solvent system in a proportion of from about 1.0 to about 10.0 weight percent, preferably from about 4.0 to 6.0 percent, and more preferably about 5.0 percent of a solvent. Preferred solvents also function as lipophilic emollients, assist in the solubilization of the ingredients and are miscible with the volatile carrier solvent (eg, dimethicone). One or more oil-soluble moisturizers, for example lauryl PCA, may be used in a ratio of from about 0.4 to about 2.5 percent, preferably about 0.5 percent, or cetyl dimethicone, in a ratio from about
1. 0 to about 5.0 weight percent of the composition, to increase wetting. Cetyl Dimethicone provides a dry, light touch and aids in film formation. A moisturizer may be incorporated into the cosmetic composition of the present invention, but if incorporated, it is preferably charged to porous microspheres and dispersed in the composition. As an alternative for the incorporation of a moisturizer, or in conjunction with the incorporation of a moisturizer, a moisturizer can be applied to the skin prior to the application of the bleaching cosmetic according to the present invention. The bleaching cosmetic of the present invention works best in the presence of a water source. The water source is for the purpose of hydrating the skin. Suitable hydration sources include liquid water added specifically to hydrate the skin or incidentally, such as, directly after a bath or shower. Hydration can also be achieved through the application of a moisturizer or other aqueous phase composition. Kaolin or other oil absorbers can be used in a proportion of from about 0.50 to about 3.0 weight percent of the composition, preferably about 0.7 to 1.5 percent, and more preferably 1.0 percent. Preferred functions of the oil absorber include absorption of excess skin oils, adhesion to the skin, light diffusion, and opacification.
An opacifier, for example titanium dioxide, may be used in a proportion from about 0.10 to about 5.0 weight percent of the composition, preferably about 0.3 to
1. 0 percent, and more preferably 0.50 percent to provide coverage and help cover skin defects. A polar activating volatile solvent for the gellant, for example hexylene glycol, can be used in a proportion from about 0.75 to about 3.0 weight percent of the composition preferably less than about 2.0 percent, more preferably not more than about 1.0 percent. This will act as a plasticizer, binder, solvent and softener while providing resistance to moisture and oxidation. Preservatives such as, for example, methyl or propyl paraben, can be used in proportions of, for example, 0.1 to 0.3 weight percent, as is known to those skilled in the art. Other optional ingredients may be used, as is known to those skilled in the art, including pigments and fragrances. Some additional optional ingredients are: vitamin E linoleate, in a percentage of approximately 0.10 percent as a complementary moisturizer; Vitamin E acetate, at approximately 0.10 percent which functions as a scavenger of free radicals and an antioxidant; retinyl palmitate, at approximately 0.1 percent which functions as a retinoic acid derivative to reduce fine lines; ceramides in a percentage below approximately 0.3 percent which functions as a skin firming agent; sphingolipids, serve for the function of affirming the skin in a percentage below approximately 0.3 percent. Sphingolipids also work to improve the skin barrier, which increases hydration and decreases the penetration of irritating substances. A class of cyclomethicone compounds that is preferred for use in the cosmetic compositions of this invention is illustrated by compounds of the formula - [R? R2SiO] r, -, in which Ri and R2 is each lower alkyl having from one to four carbon atoms with or without substitutes selected from the group consisting of halo, hydroxyl, carboxyl or methoxy and n is from 3 to 6; said compounds are cyclized. The volatile cyclomethycone solvent used may be a simple one of the foregoing compounds or a mixture thereof and the compound or compounds may be a homopolymer in which all n-monomer units are similar, or a heteropolymer in which they are different. Some preferred cyclomethicones are dimethicones especially homopolymers in which n is 4 or 5; and R, and R2 is each methyl such as octamethylcyclotetrasiloxane and decamethylcyclopentasi loxane. Depending on the character of the final product composition, for example, a lotion, a powder, a cream, a stick, other optional ingredients may be used, as is known to those skilled in the art, in proportions known to those skilled in the art. technique. Such ingredients include, but are not limited to, fragrance, color, pigments, preservatives, wetting agents, oil absorbers, opacifiers, and antioxidants.
The following examples are provided to illustrate the invention. Because these examples will be for illustrative purposes only, the invention should not be limited thereto.
EXAMPLE 1 A dry mixture of ascorbic acid was produced by combining the following materials in the following proportions by weight. P / P% Ascorbic Acid 3.00 Zinc Laurato 3.00 Kaolin 1.00 Silica 0.20 Barium Sulfate 3.80 1 1.00%
EXAMPLE 2 Using the dry ascorbic acid mixture of Example 1, a cosmetic composition was prepared by mixing the ingredients below in the annotated proportions. The composition was applied to the skin which caused improved skin tone and clarification. P / p% Dimethicone, 350 Vise. 1.00 Sorbitan Isostearate 4.00 Isononyl Isononoate 5.00 PCA Lauryl 0.50 Cetil Dimethicone 2.13 Glyceryl Tribehenate 0.32 Ceresin Wax 1.43 Microcrystalline 0.32 Propyl Paraben 0.10 Methyl Paraben 0.30 Cyclomethicone 33.55 Nylon-12 / Lactic Acid (30%) 3.33 Dry Mix of Acid Ascorbic 1 1.00 Nylon-12 6.67 Beds PMMA 12.00 Tixogel RCM (trihydroxy stearin) 16.00 Tocoferol 0.50 Linoleate Tocopherol Acetate 0.50 Retinyl Palmitate. 0.10 Parsol MCX 0.50 Lavender 0.30 Hydrophobic Sphingolipids 0.50 100%
EXAMPLE 3 A dry mixture of kojic acid was produced by combining the following materials in the following proportions by weight. P / P% Zinc Laurate 1.00 Cabosil 0.41 Barium Sulfate 2.07 Disodium EDTA 0.10 FD &C Red 40 0.01 FD &C Yellow # 5 0.02 Titanium Dioxide 1.00 Methyl Paraben 0.30 Prodil Paraben 0.10 Sodium Lactate 100% 1.05 Cronic Acid 1.00 7.06%
EXAMPLE 4 Using the dried kojic acid mixture of Example 3, a cosmetic composition was prepared by mixing the ingredients listed below in the annotated proportions. The composition was applied to the skin of the hand which caused improved skin tone and clarification. P / P% Dimethicone 5.00 Cetil Dimethicone 10.00 Glyceryl Tribehenate 0.38 Paraffin Wax 1.72 Microcrystalline Wax 0.38 Cyclomethicone 17.37 Dry Mix of Cyanic Acid 7.05 Lactic Acid / Glycerin / Nylon 10.00 Nylon-12 4.00 Beds PMMA 1 1 .00 Trihydroxystearin (5.45%) / Cyclomethicone 31 .00 Tocopherol 0.20 Tocopherol acetate 0.50 Retinyl palmitate 0.10 P-Methoxycinnamate ethylhexyl 0.50 Lavender 0.30 Hydrophobic sphingolipids 0.50 100%
EXAMPLE 5 The bleaching effect of the compositions according to the present invention was tested using 3 panels of 20 women. The panelists were 35-60 and had to meet a skin classification
Fitzpatrick from I to III. The panelists were excluded with a Classification
Glogau Modified from I to IV. Skin Classification Fitzpatrick always burns easily; never tan II always burns easily; tans minimally III moderately burns; tans gradually IV burn minimally; always tan well V rarely burns; tans profusely VI never burns; Intense pigmentation Glogau smooth modification: no keratosis or marks; small moderate wrinkles: early actinic keratosis - slightly yellow skin; discoloration; early wrinkle parallel to the advanced smile line: actinic keratosis - obviously yellow skin; discoloration with wrinkle of telangiectasia - present at rest; moderate acne marks severe IV: actinic keratosis; skin cancers have occurred; wrinkles - a lot of complexion of actinic, gravitational and dynamic origin; severe acne marks.
The duration of the test was 13 weeks during which time each of the three panels used one of the following: I VISIBLE ACTION SKIN REVEALING LOTION® II An anhydrous cosmetic composition according to the present invention together with VISIBLE ACTION SKIN REVEALING LOTION® II I An anhydrous cosmetic composition according to the present invention together with a moisturizing lotion for body care. VISIBLE ACTION SKIN REVEALING LOTION® Visible action skin revealing lotion is a moisturizer produced as a combination of the following ingredients in the proportions noted as a percentage by weight.
2. 0% Acetylated Lanolin 4.0% Stearyl Alcohol and Cetearet 20 2.5% Stearyl Alcohol 5.0% Butyl Ether PPG-14 1 .0% Ethyl Acetate, Acetylate 0.25% Dimethicone 70.5% Water 3.0% Methyl Gluceth-10 0.25% Xanthan Gum 3.0% Water 30.% Lactic acid 88% 3.0% Sodium lactate 0.20% Propyl butylcarbamate iodine 0.20% DMDM 0.08% Hydantoin Japanese green tea Actifilta 0.20% Wheat-Barley-Soy-Millet 0.50% Retinyl Palmitate 0.25% Fragrance 0.06% Bisabolol
The Anhydrous Cosmetic according to the present invention. The anhydrous cosmetic composition according to the present invention is a skin whitening or lightening composition. The anhydrous composition includes the following ingredients as a percentage by weight: 5.0% Dimethicone 10.0% Cetyl Dimethicone 0.38% Glycerium Tribehenate 1.72% Paraffin Wax 0.38% Microcrystalline Wax 10.4% Cyclomethicone 6.97% Cyclomethicone 1.05% Sodium Lactate 6.0% Dry mix acid 10.0% Lactic acid mixture 4.0% Nylon 12 1 1.0% Beds PMMA 31.0% Tixogel RCM 0.2% Tocopherol 0.5% Tocopherol acetate 0.1% Retinyl palmitate 0.5% Ethylhexyl P-methoxycinnamate 0.3% Lavender 0.5% Hydrophobic sphingolipids
The compositions according to the invention resulted in an improvement of 20 to 35% in uniformity of skin tone, an increase of 30 to 35% in skin elasticity, an improvement of 50 to 60% of skin firmness, a reduction of 30 to 80% in the appearance of wrinkling, an improvement of 30 to 40% in clarity of skin, a reduction of 30 to 40% in fine lines, a reduction of 40 to 50% in roughness of skin, and an improvement in
to 30% in the overall condition of the skin. Although illustrative embodiments of the invention have been described above and are appended, it is understood, of course, that various modifications will be apparent to those of ordinary skill in the art.
Claims (17)
1 . A topically applied cosmetic composition comprising: a) a bleaching agent selected from the group consisting of kojic acid and its derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures; b) an exfoliant selected from the group consisting of lactic acid, glycolic acid, malic acid, citric acid and salicylic acid; c) a sufficient amount of an adsorbent or carrier of particulate adsorbent to support said exfoliant; and d) a cosmetic base, said base having a sufficient amount of a film-forming agent to produce a desired cosmetic film when said cosmetic composition is applied to the skin. The cosmetic composition according to claim 1, wherein said cosmetic base is a hydrophobic cosmetic base, essentially anhydrous.
3. The cosmetic composition according to claim 1, further comprising an anti-aging composition selected from the group consisting of Vitamin A Palmitate and retinol and its derivatives.
4. The cosmetic composition according to claim 2, wherein said composition further includes an anhydrous gellant.
The cosmetic composition according to claim 4, wherein said anhydrous gellant is selected from castor oil derivatives, silicone polymers, silicone gums, bentonite clays, and styrene / ethylene / propylene block copolymers.
6. The cosmetic composition according to claim 5, wherein said anhydrous gellant is trihydroxystearin.
The cosmetic composition according to claim 2, wherein said hydrophobic phase cosmetic base includes one or more solvents selected from a polar glycerin solvent, a silicone solvent, and mixtures thereof.
8. A stabilized bleaching composition comprising: a bleach selected from kojic acid and its derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures; and a selected gellant of castor oil derivatives, silicone polymers, silicone gums, bentonite clays, and styrene / ethylene / propylene block copolymers.
9. The bleaching composition according to claim 8, wherein the bleach is selected from kojic acid, ascorbic acid and mixtures thereof and the gellant is selected from trihydroxystearin.
A method for skin lightening comprising: applying to the surface of the skin a source of water followed by the application to said skin of a bleaching cosmetic composition comprising: a) a bleaching agent selected from the group consisting of kojic acid and Their derivatives; ascorbic acid and its derivatives, including magnesium ascorbic acid; hydroquinone; extract of Arctostaphylos uva-ursi; licorice extract; blackberry extract; arbutin; and its mixtures; b) an exfoliant selected from the group consisting of lactic acid, glycolic acid, malic acid, citric acid and salicylic acid; c) a sufficient amount of an adsorbent or carrier of particulate adsorbent to support said exfoliant; and d) a cosmetic base, said base having a sufficient amount of a film-forming agent to produce a desired cosmetic film when said cosmetic composition is applied to the skin.
The method according to claim 10, wherein said cosmetic base is a hydrophobic cosmetic base, essentially anhydrous.
The method according to claim 10, wherein said bleaching cosmetic further comprises an anti-aging composition selected from the group consisting of Vitamin A Palmitate and retinol and its derivatives.
13. The method according to claim 1, wherein said bleaching composition further includes an anhydrous gellant.
The method according to claim 13, wherein said anhydrous gellant is selected from castor oil derivatives, silicone polymers, silicone gums, bentonite clays, and styrene / ethylene / propylene block copolymers.
15. The cosmetic composition according to claim 14, wherein said anhydrous gelant is trihydroxystearin.
The method according to claim 1, wherein said hydrophobic phase cosmetic base includes one or more solvents selected from a polar glycerin solvent, a silicone solvent, and mixtures thereof.
17. An essentially anhydrous, hydrophobic, topically applied cosmetic composition comprising: a) a bleaching agent selected from the group consisting of kojic acid, ascorbic acid, and mixtures thereof; b) a lactic acid exfoliant; c) an anti-aging agent selected from Vitamin A Palmitate and retinol and its derivatives; d) a sufficient amount of a particulate adsorbent adsorbent or carrier to support the exfoliant; and e) a hydrophobic, essentially anhydrous cosmetic base said base having a sufficient amount of a film forming agent to produce a desired cosmetic film when said cosmetic composition is applied to the skin.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/050383 | 1997-06-20 | ||
| US050383 | 1997-06-20 | ||
| US885884 | 1997-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA99012039A true MXPA99012039A (en) | 2000-12-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1006995A1 (en) | Cosmetic composition containing a whitening agent and an exfoliant | |
| KR101247693B1 (en) | Sebum absorption compositions | |
| WO1996021422A1 (en) | Anhydrous cosmetic compositions with dermatologically active agents | |
| HU216805B (en) | Surfactant-free oil-in-water emulsion stabilized by hollow thermoplastic particles and its use for cosmetical and/or dermatological purposes | |
| JP5822427B2 (en) | Cosmetic composition comprising an ascorbic acid or salicylic acid compound | |
| JP4242351B2 (en) | Oil-absorbing topical composition and method using the same | |
| KR102502514B1 (en) | Cosmetic compositions for moisturizing | |
| PL189774B1 (en) | Cosmetic composition containing antiperspirant or deodorising agent and moistening cream | |
| CA2750146C (en) | Matte skin finish compositions | |
| WO2020127991A1 (en) | Matt-effect cosmetic composition | |
| JPH11130652A (en) | Skin cosmetics | |
| KR20010041868A (en) | Skin moisturizing compositions | |
| JP3657752B2 (en) | Topical skin preparation | |
| MXPA99012039A (en) | Cosmetic composition containing a whitening agent and an exfoliant | |
| JP2009234933A (en) | Skin external preparation | |
| EP1596820B1 (en) | Ambiphilic porous matrix | |
| MXPA97005234A (en) | Cosmetic compositions anhydration with agents dermatologically acti | |
| CZ462799A3 (en) | Cosmetic preparation containing bleaching agent and peeling-causing agent | |
| KR100431270B1 (en) | Anti-wrinkle solid cosmetic composition | |
| KR20070051912A (en) | Moisturizers containing α-glycosyl glycyrrhizin as an active ingredient and their uses | |
| BR112021011123B1 (en) | COMPOSITION, USE THEREOF, COSMETIC PROCESS FOR CARE OF A KERATIN MATERIAL, NOTABLY THE SKIN, AND MORE PARTICULARLY THE SKIN OF THE FACE AND PROCESS FOR MAKING THE SKIN OF THE FACE OPAQUE AND/OR FOR REDUCING ITS SHINE | |
| KR19990050828A (en) | A stick type lip cosmetic composition containing a retinoid | |
| JP2005220119A (en) | Skin beautification agent | |
| JP2004277366A (en) | Solid powder cosmetic | |
| HK40057064B (en) | External preparation for skin for wrinkle improvement |